Evidence map›Paper›PMID 32101459›Full record

ArticleAmerican journal of respiratory cell and molecular biology2020

Serine Protease Imbalance in the Small Airways and Development of Centrilobular Emphysema in Chronic Obstructive Pulmonary Disease.

Kiyoshi Uemasu, Naoya Tanabe, Kazuya Tanimura, Koichi Hasegawa, Tatsushi Mizutani, Yoko Hamakawa, Susumu Sato, Emiko Ogawa, Matthew J Thomas, Machiko Ikegami and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Case report of severe pneumothorax due to lung cancer treated with anlotinib.The Journal of international medical research · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Update in Chronic Obstructive Pulmonary Disease 2020.American journal of respiratory and critical care medicine · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Kiyoshi UemasuDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-5818-3028
Naoya TanabeDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-7481-0212
Kazuya TanimuraDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-3406-9394
Koichi HasegawaDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tatsushi MizutaniDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yoko HamakawaDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Susumu SatoDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-9626-1090
Emiko OgawaDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Matthew J ThomasDepartment of Immunology and Respiratory Disease Research, Boehringer Ingelheim Pharma GmbH & Ko KG, Biberach an der Riss, Germany.
Machiko IkegamiDivision of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio; and.
Shigeo MuroDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-7452-9191
Toyohiro HiraiDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Atsuyasu SatoDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-8068-9984
Kyoto University · JPBoehringer Ingelheim (Germany) · DECincinnati Children's Hospital Medical Center · USShiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelial dysfunction in the small airways may cause the development of emphysema in chronic obstructive pulmonary disease. C/EBPα (CCAAT/enhancer binding protein-α), a transcription factor, is required for lung maturation during development, and is also important for lung homeostasis after birth, including the maintenance of serine protease/antiprotease balance in the bronchiolar epithelium. This study aimed to show the roles of C/EBPα in the distal airway during chronic cigarette smoke exposure in mice and in the small airways in smokers. In a model of chronic smoke exposure using epithelial cell-specific C/EBPα-knockout mice, significant pathological phenotypes, such as higher protease activity, impaired ciliated cell regeneration, epithelial cell barrier dysfunction via reduced zonula occludens-1 (Zo-1), and decreased alveolar attachments, were found in C/EBPα-knockout mice compared with control mice. We found that

Indexed as

AnimalsBronchiolesCCAAT-Enhancer-Binding ProteinsHumansLungMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicPulmonary Disease, Chronic ObstructivePulmonary EmphysemaSerine Peptidase Inhibitor Kazal-Type 5Serine ProteasesSmokingCCAAT-Enhancer-Binding ProteinsSerine Peptidase Inhibitor Kazal-Type 5Serine ProteasesCCAAT/enhancer binding protein-αCOPDlymphoepithelial Kazal-type–related inhibitorsmall airway

Identifiers

PMID32101459
OpenAlexW3008495660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.